MedTrace Logo

Interactive Study to Increase Glaucoma Adherence to Treatment

NCT00794170 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 312

Last updated 2014-06-09

Study results available
· View outcomes & findings →

Summary

Study participants who receive the I-SIGHT intervention will have higher rates of glaucoma treatment compliance (e.g., medication-taking and refill compliance, return for clinical follow-up) and more positive eye health outcomes at 12-month follow-up than participants who receive the control group intervention.

Conditions

Interventions

BEHAVIORAL

Telephone and Print based intervention

Thiss intervention consisted of tailored phone calls and follow-up mailings.

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Karen Glanz, PhD, MPH · Emory University

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2010-06-30
Completion
2010-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00794170 on ClinicalTrials.gov